Globe Life Inc. (NYSE: GL) is recognized among the 10 Most Profitable Undervalued Stocks to Buy. JPMorgan analyst raises price target to $181 and maintains an Overweight rating, following company’s latest earnings update and fiscal 2026 outlook. Fourth-quarter revenue slightly below estimates at $1.52 billion, but fiscal 2026 earnings outlook remains positive at $14.95 to $15.65 per share.

Globe Life Inc. (NYSE: GL) offers life and supplemental health insurance products to lower-middle- and middle-income households in the U.S. Operating across Life Insurance, Supplemental Health Insurance, and Investments, company provides whole and term life policies, Medicare supplement, and limited-benefit health products like accident, cancer, and critical illness coverage.

While Globe Life Inc. presents investment potential, some AI stocks may offer greater upside and lower downside risk. For an undervalued AI stock with potential benefits from Trump-era tariffs and onshoring trend, check out the free report on the best short-term AI stock. No disclosures mentioned in the article.

Read more at Yahoo Finance: JPMorgan Raises Price Target on Globe Life Inc. (GL) to $181 and Reiterates an Overweight Rating